Amended Report of Foreign Issuer (6-k/a)
September 17 2020 - 11:49AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K/A
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of September, 2020
Commission
File Number: 001-36582
Auris
Medical Holding Ltd.
(Exact
name of registrant as specified in its charter)
Clarendon
House,
2 Church Street
Hamilton HM11, Bermuda
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No ☒
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No ☒
EXPLANATORY
NOTE
This
Amendment No. 1 to the Report on Form 6-K for the quarter ended June 30, 2020, originally filed with the Securities and Exchange
Commission on September 17, 2020, is being filed solely for the purposes of furnishing Interactive Data File disclosure as Exhibit
101 in accordance with Rule 405 of Regulation S-T. This Exhibit was not previously filed.
Other
than as expressly set forth above, this Form 6-K/A does not, and does not purport to, amend, update or restate the information
in any other item of the Form 6-K.
INCORPORATION
BY REFERENCE
Exhibits
99.1 and 99.2 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-3 (Registration Number 333-228121) and the registration statement on Form S-8 (Registration Number 333-232735) of Auris Medical
Holding Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or
reports subsequently filed or furnished.
Exhibit
99.3 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Auris Medical Holding Ltd.
|
|
|
|
|
By:
|
/s/ Elmar Schaerli
|
|
|
Name:
|
Elmar Schaerli
|
|
|
Title:
|
Chief Financial Officer
|
Date:
September 17, 2020
EXHIBIT INDEX
3
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2023 to Sep 2024